Tennessee 114th General Assembly Status: Enacted 1 R cosponsors

SB 0436 — AN ACT to amend Tennessee Code Annotated, Title 4; Title 53; Title 56; Title 68 and Title 71, relative to biosimilar medicine.

Last action — Comp. became Pub. Ch. 206

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced January 28, 2025. Enacted.

Signed by Governor Bill Lee (Republican) on April 02, 2025.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 72% · moderate confidence

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.

Bill Text

Action History

  1. Filed for introduction

  2. Intro., P1C.

  3. P2C, ref. to Insurance Committee

  4. Assigned to s/c Insurance Subcommittee

  5. Placed on s/c cal Insurance Subcommittee for 3/12/2025

  6. Rec for pass if am by s/c ref. to Insurance Committee

  7. Placed on cal. Insurance Committee for 3/19/2025

  8. Rec. for pass. if am., ref. to Calendar & Rules Committee

  9. Placed on cal. Calendar & Rules Committee for 3/27/2025

  10. H. Placed on Regular Calendar for 3/31/2025

  11. H. adopted am. (Amendment 1 - HA0140)

  12. Sponsor(s) Added.

  13. Passed H., as am., Ayes 92, Nays 1, PNV 0

  14. Engrossed; ready for transmission to Sen.

  15. Received from House, Passed on First Consideration

  16. Senate substituted House Bill for companion Senate Bill.

  17. Amendment withdrawn. (Amendment 1 - SA0236)

  18. Passed Senate, Ayes 30, Nays 0

  19. Enrolled; ready for sig. of H. Speaker.

  20. Signed by H. Speaker

  21. Signed by Senate Speaker

  22. Transmitted to Governor for his action.

  23. Signed by Governor.

  24. Pub. Ch. 206

  25. Effective date(s) 04/11/2025

  26. Filed for introduction

  27. Introduced, Passed on First Consideration

  28. Passed on Second Consideration, refer to Senate Commerce and Labor Committee

  29. Placed on Senate Commerce and Labor Committee calendar for 3/18/2025

  30. Placed on Senate Commerce and Labor Committee calendar for 3/18/2025

  31. Action deferred in Senate Commerce and Labor Committee to 3/25/2025

  32. Placed on Senate Commerce and Labor Committee calendar for 3/25/2025

  33. Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0

  34. Placed on Senate Regular Calendar for 3/31/2025

  35. Companion House Bill substituted

  36. Comp. became Pub. Ch. 206

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 132 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (132)

132 members have not signed on to this bill.

Show all 132 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 0436 do?
Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.
Who sponsors SB 0436?
SB 0436 is sponsored by Reeves, Shane (Republican).
What is the current status of SB 0436?
This bill has been enacted into law. Introduced January 28, 2025. Enacted.
Where can I track SB 0436?
Track SB 0436 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 0436

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 0436

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →